Publications by authors named "Renata A Tassi"

Claim this Profile
F
FXYD5 (Dysadherin) upregulation predicts shorter survival and reveals platinum resistance in high-grade serous ovarian cancer patients.
Renata A Tassi, Angela Gambino, Laura Ardighieri, Eliana Bignotti, Paola Todeschini

Br J Cancer· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
Renata A Tassi, Paola Todeschini, Eric R Siegel, Stefano Calza, Paolo Cappella

J Exp Clin Cancer Res· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis.
Laura Zanotti, Chiara Romani, Laura Tassone, Paola Todeschini, Renata Alessandra Tassi

BMC Cancer· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of stably expressed reference small non-coding RNAs for microRNA quantification in high-grade serous ovarian carcinoma tissues.
Eliana Bignotti, Stefano Calza, Renata A Tassi, Laura Zanotti, Elisabetta Bandiera

J Cell Mol Med· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The HIV-protease inhibitor saquinavir reduces proliferation, invasion and clonogenicity in cervical cancer cell lines.
Elisabetta Bandiera, Paola Todeschini, Chiara Romani, Laura Zanotti, Eugenio Erba, Renata Alessandra Tassi

Oncol Lett· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of optimal reference genes for gene expression normalization in a wide cohort of endometrioid endometrial carcinoma tissues.
Chiara Romani, Stefano Calza, Paola Todeschini, Renata A Tassi, Laura Zanotti

PLoS One· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secretoglobin expression in ovarian carcinoma: lipophilin B gene upregulation as an independent marker of better prognosis.
Eliana Bignotti, Renata A Tassi, Stefano Calza, Antonella Ravaggi, Elisa Rossi

J Transl Med· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and prediction of clinical outcome.
Laura Zanotti, Eliana Bignotti, Stefano Calza, Elisabetta Bandiera, Giuseppina Ruggeri, Renata A Tassi

Clin Chem Lab Med· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trop-2 protein overexpression is an independent marker for predicting disease recurrence in endometrioid endometrial carcinoma.
Eliana Bignotti, Laura Zanotti, Stefano Calza, Marcella Falchetti, Silvia Lonardi, Renata A Tassi

BMC Clin Pathol· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum human epididymis protein 4 and risk for ovarian malignancy algorithm as new diagnostic and prognostic tools for epithelial ovarian cancer management.
Elisabetta Bandiera, Chiara Romani, Claudia Specchia, Laura Zanotti, Claudio Galli, Renata A Tassi

Cancer Epidemiol Biomarkers Prev· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HE4 and epithelial ovarian cancer: comparison and clinical evaluation of two immunoassays and a combination algorithm.
Giuseppina Ruggeri, Elisabetta Bandiera, Laura Zanotti, Silvana Belloli, Antonella Ravaggi, Renata A Tassi

Clin Chim Acta· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients.
Eliana Bignotti, Paola Todeschini, Stefano Calza, Marcella Falchetti, Maria Ravanini, Renata A Tassi

Eur J Cancer· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and characterization of a human single-chain antibody fragment against claudin-3: a novel therapeutic target in ovarian and uterine carcinomas.
Chiara Romani, Fabrizio Comper, Elisabetta Bandiera, Antonella Ravaggi, Eliana Bignotti, Renata A Tassi

Am J Obstet Gynecol· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mammaglobin B is an independent prognostic marker in epithelial ovarian cancer and its expression is associated with reduced risk of disease recurrence.
Renata A Tassi, Stefano Calza, Antonella Ravaggi, Eliana Bignotti, Franco E Odicino

BMC Cancer· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overexpression of mammaglobin B in epithelial ovarian carcinomas.
Renata A Tassi, Eliana Bignotti, Elisa Rossi, Marcella Falchetti, Carla Donzelli

Gynecol Oncol· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene expression profile of ovarian serous papillary carcinomas: identification of metastasis-associated genes.
Eliana Bignotti, Renata A Tassi, Stefano Calza, Antonella Ravaggi, Elisabetta Bandiera

Am J Obstet Gynecol· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapy.
Eliana Bignotti, Renata A Tassi, Stefano Calza, Antonella Ravaggi, Chiara Romani

Gynecol Oncol· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis